1 |
Molina R, Torres MD, Moragas M et al : Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC. Anticancer Res 15: 479-484, 1995
|
2 |
Catalona WJ, Smith DS, Ratliff TL et al : Measurement of prostate-specific antigen as a screening test for prostate cancer. New Engl J Med 324 : 1156-61, 1991
DOI
ScienceOn
|
3 |
Cazzola M, Arosio P, Bellotti V et al: Immunological Reactivity of Serum Ferritin in Patients with Malignancy. Tumori 71: 547-554, 1985
|
4 |
Milman N, Kirchhoff M, J¨orgensen T: Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol 65: 96-102, 1992
DOI
ScienceOn
|
5 |
Kato H, Torigoe T : Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40: 1621, 1977
DOI
ScienceOn
|
6 |
Yamazawa K, Shimada H, Hirai M et al : Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer. American J of Obstetrics and Gynecology 197(5) , p.505.e1-505.e7, 2007
DOI
ScienceOn
|
7 |
Nagler RM, Barak M, Peled M et al: Early diagnosis and treatment monitoring roles of tumour markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85: 1018-1025, 1999
DOI
ScienceOn
|
8 |
Zhong LP, Zhu HG, Zhang CP et al : Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma. Int J Oral Maxillofac Surg 36: 230-234, 2007
DOI
ScienceOn
|
9 |
Niitsu Y, Koeski J, Watanabe N et al : Diagnosis of latent iron deficiency by serum ferritin concentration. Jpn J Clin Hematol 20: 1-7, 1979
|
10 |
Neville BW, Day YA: Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215, 2002
DOI
ScienceOn
|
11 |
Nakata B, Ogawa Y, Ishikawa T et al: Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma. Cancer 89: 1285-90, 2000
DOI
ScienceOn
|
12 |
Ogawa T, Tsurusako Y, Kimura N et al: Comparison of tomur markers in patients with squamous cell carcinoma of Head and Neck. Acta Otolaryngol Suppl 540: 72-76, 1999
DOI
ScienceOn
|
13 |
Yen TC, Lin WY, Kao CH et al: A study of a new tumour marker, Cyfra 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol Allied Sci 23: 82-86, 1998
DOI
ScienceOn
|
14 |
Watanabe N, Niitsu YU, Koseki J et al : A mechanism for evaluation of serum ferritin in malignancy: A study of nude micewith innoculated human tumors. J Clin Exp Med 110: 686-688, 1979
|
15 |
Rikushi M, Masao Y, Kotoko N et al : Clinical evaluation of serum ferritin to iron ratio in malignant diseases. Eur J Nucl Med 6: 331-336, 1981
DOI
|
16 |
Kelly WM: Tumor markers: a review. Radiography 54: 14-27, 1988
|
17 |
DelVillano B, Brennan S, Brock P et al: Radioim-munometric assay for a monoclonal antibody - Defined tumor marker, CA 19-9. Clin Chem 29; 549, 1983
|
18 |
Ceruse P, Rabilloud M, Charrie A et al: Study of Cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 114: 768-776, 2005
|
19 |
Johnson J, Wagner R, Eibling D : Radioimmunoassay for SCC antigen in the diagnosis of squamous cell carcinoma of the head and neck: A preliminary report. Princeton: Excerpta Medica 112-123, 1987
|
20 |
Ruoslahti E, Seppala M: Studies of carcinofetal proteins: physical and chemical properties of human alpha-fetoprotein. Int J Cancer 7: 218-225, 1971
DOI
|
21 |
Arosio p, Yokota M, Drysdale JW : Structural and immunological relationships of isoferritins in normal and malignant cells. Cancer Res 36: 1735-1739, 1976
|
22 |
Kurokawa H, Tsuru S, Okada M et al: Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 22: 35-38, 1993
DOI
ScienceOn
|
23 |
Lucinei RO, Alfredo RS, Sergio Z: Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 36: 191-197, 2007
DOI
ScienceOn
|
24 |
Niklinski J, Furman M, Chyczewski L et al: Evaluation of Cyfra 21-1 as a new marker for non-small cell lung cancer. Eur J Cancer Prev 3: 227-230, 1994
DOI
ScienceOn
|
25 |
Michael K, Jurgen H, Cinatanze K et al : Relevance of SCC-Ag, CEA, CA 19-9 and CA 125 for diagnosis and follow-up in oral cancer. J of Cranio-Maxillofacial Surgery 26 : 243-248, 1998
DOI
ScienceOn
|
26 |
Nakano S, Kumada T, Kitamura K et al: Clinical evaluation of serum ferritin in the diagnosis of liver disease. Jpn J Gastroenerol 76: 1306-1313, 1979
|
27 |
Doweck I, Barak M, Uri N et al: The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease. Br J Cancer 83: 1696-1701, 2000
DOI
ScienceOn
|
28 |
M. Prutki, M. Poljak-Blazi, M. Jakopovic et al: Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Letters 238: 188-196, 2006
DOI
ScienceOn
|
29 |
Sauter ER, Ridge JA, Gordon J et al: p53 overexpression correlates with increased survival in patients with squamous carcinoma of th tongue base. Am J Surg 164: 651-653, 1992
DOI
ScienceOn
|
30 |
Adelman TG, Drysdale JW : Synthesis of ferritin subunits by free and membrane bound ribosomes, New York, Grune & Stratton, 1977, p.49-65
|
31 |
Prieto J, Barry M, Sherlock S : Serrum ferritin in patients with iron overload and with acute and chronic liver disease. Gastroenterology 68: 525-533, 1975
|
32 |
Nylander K, Dabelsteen E, Hall PA: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29: 413-425, 2000
DOI
ScienceOn
|
33 |
Khademi B, Shirazi FM, Vasei M et al: The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett 184: 223-230, 2002
DOI
ScienceOn
|
34 |
Parkin DM, Bray F, Ferlay J et al: Global cancer statistics. CA Cancer J Clin 55 : 74-108, 2005
DOI
ScienceOn
|
35 |
Hashimoto T, Matsubara F: The need for primary quality control of commercially available immunoassay kits. Journal of Clinical Pathology 44 : 165-167, 1991
DOI
PUBMED
|
36 |
Doweck I, Barak M, Greenberg E et al : Cyfra 21-1: a new potential marker for squamous cell carcinoma of head neck Arch Otolaryngol Head Neck Surg 121: 177-181, 1995
DOI
ScienceOn
|
37 |
P.I. Hsu, N.H. Chow, X.Z. Lin : Prognostic significance of ferritin expression in colorectal adenocarcinoma. Anticancer Rec 5: 1087-1093, 1995
|
38 |
Clasen B, Pere P, Senekowitsch R et al: Tumorzelltod im spoegel der SCC-antigentiter? Laryngo-Rhino-Otol 70: 251-254, 1991
|
39 |
Banal A, Hacene K, Berthelot-Ruff E et al: Comparison of Cyfra 21-1 and SCC assays in head and neck tumors. Tumour Biol 22: 27-35, 2001
DOI
ScienceOn
|